Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2404207.pdf
Reference8 articles.
1. Druker BJ, Talpaz M, Resta D, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the Bcr–Abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.
2. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC . Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20: 1245–1259.
3. Sakai F, Noma S, Kurihara Y, Yamada H, Azuma A, Kudoh S et al. Leflunomide-related ILD: imaging features. Modern Rheumatol, in press.
4. Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Esperou H et al. Hypersensitivity pneumonitis related to imatinib mesylate. J Clin Oncol 2002; 20: 4271–4272.
5. Rosado MF, Donna E, Ahn YS . Challenging problems in advanced malignancy: case 3. Imatinib mesylate-induced interstitial pneumonitis. J Clin Oncol 2003; 78: 3171–3173.
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bilateral intracochlear hemorrhage: A rare onset of chronic myelogenous leukemia;Clinical Case Reports;2024-04
2. Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series;Current Problems in Cancer: Case Reports;2024-03
3. Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients;Nature Communications;2024-01-25
4. Characteristics and risk factors for drug-induced lung injury in hospitalized patients: A matched case-control study;2023-08-03
5. Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients;Drug Design, Development and Therapy;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3